These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy. Schmidt WE, Stöckmann F, Choudhury AR, Wilms HM, Siegel EG, Nustede R, Fölsch UR, Creutzfeldt W. Digestion; 1989; 44(2):105-16. PubMed ID: 2612749 [Abstract] [Full Text] [Related]
5. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Douglas BR, Woutersen RA, Jansen JB, de Jong AJ, Rovati LC, Lamers CB. Cancer Res; 1989 May 01; 49(9):2438-41. PubMed ID: 2706631 [Abstract] [Full Text] [Related]
6. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade. Varga G, Kisfalvi K, Pelosini I, D'Amato M, Scarpignato C. Br J Pharmacol; 1998 Jun 01; 124(3):435-40. PubMed ID: 9647465 [Abstract] [Full Text] [Related]
7. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Wisner JR, McLaughlin RE, Rich KA, Ozawa S, Renner IG. Gastroenterology; 1988 Jan 01; 94(1):109-13. PubMed ID: 3335282 [Abstract] [Full Text] [Related]
8. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats. Göke B, Fenchel K, Knobloch S, Arnold R, Adler G. Pancreas; 1988 Jan 01; 3(5):576-9. PubMed ID: 3186685 [Abstract] [Full Text] [Related]
9. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster. Douglas BR, Woutersen RA, Jansen JB, Rovati LC, Lamers CB. Life Sci; 1990 Jan 01; 46(4):281-6. PubMed ID: 2304371 [Abstract] [Full Text] [Related]
11. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Adler G, Reinshagen M, Koop I, Göke B, Schafmayer A, Rovati LC, Arnold R. Gastroenterology; 1989 Apr 01; 96(4):1158-64. PubMed ID: 2647576 [Abstract] [Full Text] [Related]
13. The effect of trypsin inhibitor on the pancreas and small intestine of mice. Ge YC, Morgan RG. Br J Nutr; 1993 Jul 01; 70(1):333-45. PubMed ID: 8399113 [Abstract] [Full Text] [Related]
16. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats. Löser C, Fölsch UR, Cleffmann U, Nustede R, Creutzfeldt W. Digestion; 1989 Jul 01; 43(1-2):98-112. PubMed ID: 2509268 [Abstract] [Full Text] [Related]
17. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Drozdowicz D, Kwiecień S, Hahn EG. Regul Pept; 1999 Jun 30; 82(1-3):19-33. PubMed ID: 10458643 [Abstract] [Full Text] [Related]
18. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats. Leonhardt U, Seidensticker F, Stöckmann F, Creutzfeldt W. Pancreas; 1993 Jan 30; 8(1):98-102. PubMed ID: 7678329 [Abstract] [Full Text] [Related]
19. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA. Cancer Lett; 1991 Dec 01; 60(3):205-11. PubMed ID: 1756510 [Abstract] [Full Text] [Related]
20. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats. Kisfalvi K, Friess H, Büchler MW, Tulassay Z, Varga G, Papp M. Eur J Gastroenterol Hepatol; 1996 Jan 01; 8(1):69-74. PubMed ID: 8900912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]